VIOV:NYE-Vanguard S&P Small-Cap 600 Value Index Fund ETF Shares (USD)

ETF | Small Value |

Last Closing

USD 92.03

Change

-2.06 (-2.19)%

Market Cap

N/A

Volume

0.04M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-21 )

Largest Industry Peers for Small Value

Symbol Name Price(Change) Market Cap
VBR Vanguard Small-Cap Value Index..

-3.15 (-1.54%)

USD 30.51B
IJS iShares S&P Small-Cap 600 Valu..

-2.28 (-2.08%)

USD 7.26B
DES WisdomTree U.S. SmallCap Divid..

-0.65 (-1.85%)

USD 2.05B
XSVM Invesco S&P SmallCap Value wit..

-1.35 (-2.42%)

USD 0.83B
XSLV Invesco S&P SmallCap Low Volat..

-0.75 (-1.55%)

USD 0.32B
RZV Invesco S&P SmallCap 600® Pur..

-2.87 (-2.59%)

N/A
JKL iShares Morningstar Small-Cap ..

N/A

N/A
SLYV SPDR® S&P 600 Small Cap Value..

-1.87 (-2.12%)

N/A
FDM First Trust Dow Jones Select M..

-1.30 (-1.96%)

N/A
PXSV Invesco S&P SmallCap Value wit..

-1.68 (-3.00%)

N/A

ETFs Containing VIOV

N/A

Market Performance

  Market Performance vs. Industry/Classification (Small Value) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -48.01% 45% F 9% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return -48.01% 45% F 14% F
Trailing 12 Months  
Capital Gain -36.28% 38% F 11% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -36.28% 38% F 15% F
Trailing 5 Years  
Capital Gain -30.20% 46% F 22% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -30.20% 46% F 28% F
Average Annual (5 Year Horizon)  
Capital Gain 13.07% 62% D 74% C
Dividend Return 14.77% 62% D 73% C
Total Return 1.70% 85% B 39% F
Risk Return Profile  
Volatility (Standard Deviation) 31.88% 54% F 32% F
Risk Adjusted Return 46.34% 54% F 64% D
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike